Photodynamic therapy in combination with green tea polyphenol EGCG enhances antitumor efficacy in human papillomavirus 16 (E6/E7) immortalized tumor cells

Journal of Applied Research

Volumn 10, Issue 2, 2010, Pages 58-67

  Raish, Mohammad ^a,b   Husain, Syed Zeaul Abrar ^c   Bae, Su Mi ^a   Han, Sei Jun ^d   Park, Choong Hak ^e   Shin, Jong Chul ^f   Ahn, Woong Shick ^e  

^a The Catholic University of Korea   (South Korea)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c HAMDARD UNIVERSITY   (India)

^d Chosun University   (South Korea)

^e Dankook University   (South Korea)

^f The Catholic University of Korea   (South Korea)

Author keywords

( ) epigallocatechin 3 gallate; EGCG; Green tea polyphenol; Photodynamic therapy; Radachlorin

Indexed keywords

CYCLOOXYGENASE 2; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; PHOTOSENSITIZING AGENT; POLYPHENOL; RADACHLORIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL ASSAY; CELL IMMORTALIZATION; CELL SURVIVAL; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG EFFECT; DRUG EFFICACY; DRUG EXCRETION; DRUG POTENTIATION; DRUG RESPONSE; DRUG TUMOR LEVEL; DRUG UPTAKE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; TREATMENT DURATION; TUMOR CELL; TUMOR REGRESSION; TUMOR VOLUME; WART VIRUS; WESTERN BLOTTING;

EID: 77954923919     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Gomer CJ, Rucker N, Ferrario A, Wong S. Properties and applications of photodynamic therapy. Radiat Res 1989;20:1-18.
2. Corti L, Mazzarotto R, Belfontali S, et al. Photodynamic therapy in gynaecological neoplastic diseases. J Photochem Photobiol B 1996;36:193-97.
3. Oleinick NL, Evans HH. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 1998;150:146-56.
4. Moan J, Berg K. Photochemotherapy of cancer: experimental research. Photochem Photobiol 1992;55:931-48.
5. He J, Agarwal ML, Larkin HE, Friedman LR, Xue L-Y, Oleinick NL. The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2. Photochem Photobiol 1996;64:845-52.
6. Lim DS, Ko SH, Lee CH, Ahn WS, Lee WY. DH-I-180-3-mediated photodynamic therapy: biodistribution and tumor vascular damage. Photochem Photobiol 2006;82: 600-5.
7. Lim DS, Bae SM, Kwak SY, et al. Adenovirus-mediated p53 treatment enhances photodynamic antitumor response. Hum Gene Ther 2006;17:347-52.
8. Lim DS, Ko SH, Lee CH, Ahn WS, Lee WY. DH-I-180-3 Mediated Photodynamic Therapy: Its Biodistribution and Tumor Vascular Damage. Photochem Photobiol In press.
9. Ahn WS, Bae SM, Huh SW, et al. Necrosis-like death with plasma membrane damage against cervical cancer cells by photodynamic therapy. Int J Gynecol Cancer 2004;14:475-82.
10. Agarwal ML, Clay ME, Harvey EJ, Evans HH, Antunez AR, Oleinick NL. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res 1991;51:5993-96.
11. Laukka MA, Wang KK, Bonner JA. Apoptosis occurs in lymphoma cells but not in hepatoma cells following ionizing radiation and photodynamic therapy. Dig Dis Sci 1994; 39:2467-75.
12. Luo Y, Chang CK. Kessel D. Rapid initiation of apoptosis by photodynamic therapy. Photochem Photobiol 1996;63:528-34.
13. Colussi VC, Feyes DK, Mulvihill JW, et al. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts. Photochem Photobiol 1999;69:236-41.
14. Xu Xc, Mitchell MF, Silva E, Jetten A, Lotan R. Decreased expression of retinoic acid receptors, transforming growth factor beta, involucrin, and comifin in cervical intraepithelial neoplasia. Chin Cancer Res 1999;5:1503-08.
15. Suganuma M, Ohkura Y, Okabe S, Fujiki H. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal timor formation in Min mice. J Cancer Res Clin Oncol 2004;127:69-2.
16. Fujiki H, Suganuma M, Okabe S, et al. Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. Mutat Res 2001;480-81:299-4.
17. Jin YM, Nam SL. Ahn WS. Growth inhibition and induction of apoptosis in cervival cancer cell line by green tea polyphenols. Korean Journal of Obstetrics and Gynecology 2002;45:560-8.
18. Graham HN. Green tea composition, consumption and polyphenolchemistry. Prev Med 1992;21:334-50.
19. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin- 3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Nat Cancer Inst 1997;89:1881-86.
20. Ji BT, Chow WH, Hsing AW, et al. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer 1997;70:255-8.
21. Follen M, Meyskens FL Jr, Atkinson EN, Schouuenfeld D. Why most randomized phase II cervical cancer chemoprevention trials are uninformative: lessons for the future. J Natl Cancer Inst 2001;93:1293-6.
22. Gao H. Kuroyanagi M, Wu L, Kawahara N, Yasuno T, Nakamura Y. Antitumor-promoting constituents from Dioscorea bulbifera L. in JB6 mouse epidermal cells. Bio pharm Bull 2002;25:1241-3.
23. Sang S, Cheng X, Stark RE, Rosen RT, Yang CS, Ho CT. Chemical studies on antioxidant mechanism of tea catechins; analysis of radical reaction products of catechin and epicatechin with 2,2-diphenyl-1-picrylhydrazyl. Bioorg Med Chem 2002;10:223-7.
24. Pronix S, Liederer BM, Blanchard J. Preformulation study of epigallo-catechin, a promising antioxidant for topical skin cancer prevention. J Pharm Sci 2002;92:111-6.
25. Paschka AG, Butler R, Young CY. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett 1998;130:1-7.
26. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin- 3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Nat Cancer Inst 1997;89:1881-6.
27. Otsuka T, Ogo T, Eto T, Asano Y, Suganuma M, Niho Y. Growth inhibition of leukemic cells by (-)-apigallocatechin-3-gallate, the main constituent of green tea. Life Sci 1998;63:1397-3.
28. Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998;19:611-6.
29. Hussain T, Gupta S, Adhami VM, Mukhtar H. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer 2005;113:660-9.
30. Kundu JK, Na HK, Chun KS, et al. Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J Nutr 2003;133:3805S-10S.
31. Tang FY, Nguyen N, Meydani M. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer 2003;106:871-8.
32. Fassina G, Vene R, Morini M, et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin Cancer Res 2004;10:4865-73.
33. Ferrario A, Fisher AM, Rucker N, Gomer CJ. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res 2005;65:9473-78.
34. Luna MC, Ferrario A, Wong S, Fisher AM, Gomer CJ. Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter. Cancer Res 2000;60:1637-44.
35. Zhou Q, Olivo M, Lye KY, Moore S, Sharma A, Chowbay B. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models. Cancer Chemother Pharmacol 2005;56:569-77.
36. Brown SB, Brown FA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lance Oncol 2004;5:497-8.
37. Moan J, Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime if singlet oxygen. Photochem Photobiol 1991;53:549-53.
38. Min HP, Liang YC, Shiau SY, Zhu NQ, Ho CT, Lin JK. Induction of apoptosis by the oolong tea polyphenol theasinensin a through cytochrome c release and activation of caspase-9 and caspase-3 in human U937 cells. J Agric Food Chem 2000;48:6337-46.
39. Ahn WS, Huh SW, Bae SM, et al. A major constituent of green tea, EGCG, inhibits the growth of human cervical cancer cell lines, CaSki cells, through apoptosis, G1 arrest, and regulation of gene expression. DNA Cell Biol 2003; 22:217-24.
40. Otsuka T, Ogo T, Eto T, Asano Y, Suganuma M, Niho Y. Growth inhibition of leukemic cells by(-)-apigallocatechin -3-gallate, the main constituent of green tea. Life Sci 1998; 63:1397-3.
41. Nakazato T, Ito K, Ikeda Y, Kizaki M. Green Tea Component, Catechin, Induces Apoptosis of Human Malignant B Cells via Production of Reactive Oxygen Species. Clin Cancer Res 2005;11:6040-9.
42. Ferrario A, Chantrain CF, von Tiehl K, et al. The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res 2004;64:2328-32.